ANGO vs GILD · rev $292.5M vs P/E 18, rev $29.44B
AngioDynamics Inc (ANGO) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ANGO currently screens at market cap $378.5M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ANGO and GILD stock pages for the full models.
Not investment advice.